Patents Assigned to ORBIO CORPORATION
  • Publication number: 20240327450
    Abstract: Provided are novel glucose derivatives and an anticancer agent using the same. The glucose derivatives according to the present invention consist of an L-glucose derivative represented by general formula (1) and a D-glucose derivative represented by general formula (2). In formula (1): XL2 represents an —SAuRL2 group; and XL1, XL3, XL4 and XL5 independently represent an —ORL1 group, an —NH2 group or a fluorine atom. RL2 represents a ligand, and RL1 represents a hydrogen atom or an organic group. In formula (2): XD2 represents an —SAuRD2 group; and XD1, XD3, XD4 and XD5 independently represent an —ORD1 group, an —NH2 group or a fluorine atom. RD2 represents a ligand, and RD1 represents a hydrogen atom or an organic group. The anticancer agent according to the present invention comprises at least one of the aforesaid glucose derivatives.
    Type: Application
    Filed: October 3, 2022
    Publication date: October 3, 2024
    Applicant: ORBIO CORPORATION
    Inventors: Eiichi YAMAGUCHI, Katsuya YAMADA, Koki ONO, Kota TANAKA, Hideki IIJIMA